State Ledger
Company profile

JUPITER NEUROSCIENCES, INC. CIK 1679628

Ticker
JUNS (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Jupiter, FL 33477
Fiscal year end
2025 (FY)
Market Data
Close
$2.81
Change
+$0.07
Change %
2.55%
Volume
603

JUNS · trading date Oct 8, 2026 · previous close $2.74 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$21.8K
Net income
-$8.64M
Total assets
$5.56M
Total liabilities
$7.40M
Stockholders' equity
-$1.83M
Cash & equivalents
—
Operating income
-$8.91M
Operating cash flow
-$5.41M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-04-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-40,873.2%
Net margin
-39,662.8%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
132.9%
Equity / assets
-32.9%
CapEx / revenue
—
Operating cash flow / net income
0.63×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $21.8K -$8.64M $5.56M $7.40M -$1.83M
2024 — -$2.44M $6.20M $2.03M $4.17M
2023 — -$4.78M $148.6K $5.95M -$5.80M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form D
2026-09-04
Financials filed via
Form 10-K
filed 2026-04-01

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Jupiter, FL 33477
1001 NORTH US HWY 1
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:26 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies